Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACKR3 | P25106 | 1/20 | 0.54 |
| ▸ | GAA | P10253 | 1/20 | 0.50 |
| ▸ | USP2 | O75604 | 1/20 | 0.49 |
| ▸ | BCHE | P06276 | 1/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.45 |
| ▸ | GFER | P55789 | 1/20 | 0.45 |
| ▸ | HPGD | P15428 | 1/20 | 0.45 |
| ▸ | MMP2 | P08253 | 2/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | CNR1 | P21554 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1986411 | 0.87 | ALOX15 (0.55) | ACKR3GAAALOX15CYP2C19HPGD | |
| SCHEMBL9099535 | 0.84 | USP2 (0.57) | ACKR3GAAUSP2BCHEALOX15 | |
| SCHEMBL6807560 | 0.79 | HPGD (0.48) | ACKR3GAABCHEHPGDL3MBTL1 | |
| SCHEMBL4861149 | 0.78 | USP2 (0.57) | ACKR3GAAUSP2BCHEALOX15 | |
| SCHEMBL9549340 | 0.78 | DNM1 (0.62) | GAAUSP2BCHEHPGDMMP2 | |
| SCHEMBL5404064 | 0.78 | LMNA (0.57) | BCHEHPGDL3MBTL1KDM4ELMNA | |
| SCHEMBL2001669 | 0.78 | HPGD (0.65) | HPGDMAPTMTNR1A | |
| SCHEMBL27527714 | 0.78 | HPGD (0.65) | HPGDMAPTMTNR1A | |
| SCHEMBL1984651 | 0.78 | HPGD (0.49) | ACKR3GAAHPGDMTNR1AMTNR1B | |
| SCHEMBL1992751 | 0.76 | ACKR3 (0.55) | ACKR3GAAHPGDL3MBTL1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1026150-B1 | (2-oxy substituted)-phenylalkanamide derivative, hair growth promoter and external composition for skin using the same | SHISEIDO CO LTD (JP) | 2011-06-29 | — | — | EP | disclosed |
| US-6573297-B2 | Applying an effective amount of (2-substituted oxyphenyl)alkanamide derivatives to the skin of a mammal for promoting hair growth | SHISEIDO CO., LTD. (JP) | 2003-06-03 | — | — | US | disclosed |
| US-20020052498-A1 | (2-substituted oxyphenyl)alkanamide derivative, hair growth promoter and external composition for skin using the same | SHISEIDO CO., LTD. (JP) | 2002-05-02 | — | — | US | disclosed |
| US-6339154-B1 | THERAPY OF HAIR LOSS IN MAMMALS AND, IN PARTICULAR, IN HUMAN | SHISEIDO CO, LTD. (JP) | 2002-01-15 | — | — | US | disclosed |
| EP-1026150-A1 | (2-oxy substituted)-phenylalkanamide derivative, hair growth promoter and external composition for skin using the same | SHISEIDO COMPANY LIMITED (JP) | 2000-08-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020052498-A1 | (2-substituted oxyphenyl)alkanamide derivative, hair growth promoter and external composition for skin using the same | NR2E1, NCOR2, DECR2 | ACKR3 802/4885GAA 4713/4885USP2 2786/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.